Millipede, Inc
1745 Copperhill Parkway
Suite #6
Santa Rosa
California
95403
United States
Tel: 707-524-7500
Fax: 707-524-7501
Website: http://www.millipedemedical.com
Email: info@millipedemedical.com
About Millipede, Inc
Millipede is based in Santa Rosa California and was founded in August of 2012 by Steven F. Bolling, a renowned cardiac surgeon at the University of Michigan, with the goal of providing the gold standard of heart valve repair – a complete annuloplasty ring – delivered via a transcatheter approach. An innovative repair solution with the potential to not only decrease mortality and morbidity, but also expand care options for millions of people around the world.YEAR FOUNDED:
August 2012
LEADERSHIP:
CEO: Randy Lashinski
CFO: Jay Shukert
COO: Richard Glenn
6 articles about Millipede, Inc
-
Boston Scientific is exercising its option to buy the remaining shares of Santa Rosa, Calif.-based Millipede. The original deal was entered into in January 2018, when Boston Scientific acquired $90 million shares with the option to buy the remaining $325 million, which the company did yesterday.
-
Boston Scientific Exercises Option to Acquire Millipede, Inc.
12/27/2018
Acquisition will expand structural heart portfolio to include transcatheter mitral annuloplasty repair system
-
Boston Sci has the option to acquire the remaining shares of the company at any time prior to the completion of a first in human clinical study that meets certain parameters.
-
Millipede Announces Peer Reviewed Publications
10/30/2017
Millipede today announced the release of two peer-reviewed publications describing the use and efficacy of the transcatheter Millipede IRIS mitral annuloplasty ring.
-
Millipede Announces First Cases With 50mm Transcatheter Annuloplasty Ring Expanding Treatable Patient Population
7/24/2017
-
Millipede Announces Successful Clinical Use Of The First Adjustable, Retrievable Transcatheter Complete Mitral Annuloplasty Ring
5/12/2017